VYGR 内幕交易
VYGR 的 SEC Form 4 内幕交易记录
总交易
34
买入
0
买入总额
-
卖出总额
$435K
| 信号 | 内幕人 | 职位 | 方向 | 股数 | 价格 | 金额 | 日期 | 信号原因 |
|---|---|---|---|---|---|---|---|---|
| ★★★★★(40) | SANDROCK ALFRED | President and CEO | 卖出 | 12,192 | $3.78 | $46K | 2026-02-10 | CEO卖出, 董事卖出 |
| ★★★★★(30) | SANDROCK ALFRED | President and CEO | 卖出 | 11,511 | $3.87 | $45K | 2026-04-02 | CEO卖出, 董事卖出 |
| ★★★★★(30) | SANDROCK ALFRED | President and CEO | 卖出 | 14,197 | $3.79 | $54K | 2026-02-24 | CEO卖出, 董事卖出 |
| ★★★★★(30) | SANDROCK ALFRED | President and CEO | 卖出 | 11,732 | $3.41 | $40K | 2026-02-18 | CEO卖出, 董事卖出 |
| ★★★★★(28) | JORGENSEN NATHAN D. | Chief Financial Officer | 卖出 | 25,000 | $3.88 | $97K | 2026-05-15 | CFO卖出, 非10b5-1计划卖出 |
| ★★★★★(28) | JORGENSEN NATHAN D. | Chief Financial Officer | 卖出 | 9,406 | $4.24 | $40K | 2026-05-15 | CFO卖出, 非10b5-1计划卖出 |
| ★★★★★(25) | SWARTZ ROBIN | COO & CBO | 卖出 | 4,569 | $3.85 | $18K | 2026-02-10 | C-suite卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | JORGENSEN NATHAN D. | Chief Financial Officer | 卖出 | 4,668 | $3.77 | $18K | 2026-02-24 | CFO卖出 |
| ★★★★★(18) | CARTER TODD ALFRED | Chief Scientific Officer | 卖出 | 3,525 | $3.85 | $14K | 2026-02-10 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(15) | SWARTZ ROBIN | COO & CBO | 卖出 | 6,458 | $3.77 | $24K | 2026-02-24 | C-suite卖出 |
| ★★★★★(15) | SWARTZ ROBIN | COO & CBO | 卖出 | 3,882 | $3.44 | $13K | 2026-02-18 | C-suite卖出 |
| ★★★★★(8) | CARTER TODD ALFRED | Chief Scientific Officer | 卖出 | 4,174 | $3.76 | $16K | 2026-02-24 | 高管卖出 |
| ★★★★★(8) | CARTER TODD ALFRED | Chief Scientific Officer | 卖出 | 3,301 | $3.44 | $11K | 2026-02-18 | 高管卖出 |
| ★★★★★(0) | MACKEY CATHERINE J | - | 卖出 | 30,000 | - | - | 2026-06-09 | |
| ★★★★★(0) | HIGGINS MICHAEL J | - | 卖出 | 30,000 | - | - | 2026-06-09 | |
| ★★★★★(0) | ONYIA JUDE | - | 卖出 | 30,000 | - | - | 2026-06-09 | |
| ★★★★★(0) | VITALE NANCY | - | 卖出 | 30,000 | - | - | 2026-06-09 | |
| ★★★★★(0) | GERAGHTY JAMES A | - | 卖出 | 30,000 | - | - | 2026-06-09 | |
| ★★★★★(0) | HYMAN STEVEN | - | 卖出 | 30,000 | - | - | 2026-06-09 | |
| ★★★★★(0) | COLON GRACE | - | 卖出 | 30,000 | - | - | 2026-06-09 | |
| ★★★★★(0) | PIERCE GLENN | - | 卖出 | 30,000 | - | - | 2026-06-09 | |
| ★★★★★(0) | SCANGOS GEORGE A | - | 卖出 | 30,000 | - | - | 2026-06-09 | |
| ★★★★★(0) | QUINLAN AMY | Principal Accounting Officer | 卖出 | 0 | - | - | 2026-05-08 | |
| ★★★★★(0) | SHIFERMAN GREGORY L. | SVP and General Counsel | 卖出 | 50,000 | - | - | 2026-04-01 | |
| ★★★★★(0) | CARTER TODD ALFRED | Chief Scientific Officer | 卖出 | 33,000 | - | - | 2026-02-06 | |
| ★★★★★(0) | SANDROCK ALFRED | President and CEO | 卖出 | 86,250 | - | - | 2026-02-06 | |
| ★★★★★(0) | FERGUSON TOBY | Chief Medical Officer | 卖出 | 45,000 | - | - | 2026-02-06 | |
| ★★★★★(0) | SWARTZ ROBIN | COO & CBO | 卖出 | 45,000 | - | - | 2026-02-06 | |
| ★★★★★(0) | FERGUSON TOBY | Chief Medical Officer | 卖出 | 210,000 | - | - | 2026-02-06 | |
| ★★★★★(0) | SWARTZ ROBIN | COO & CBO | 卖出 | 210,000 | - | - | 2026-02-06 | |
| ★★★★★(0) | SANDROCK ALFRED | President and CEO | 卖出 | 402,500 | - | - | 2026-02-06 | |
| ★★★★★(0) | JORGENSEN NATHAN D. | Chief Financial Officer | 卖出 | 32,250 | - | - | 2026-02-06 | |
| ★★★★★(0) | JORGENSEN NATHAN D. | Chief Financial Officer | 卖出 | 150,500 | - | - | 2026-02-06 | |
| ★★★★★(0) | CARTER TODD ALFRED | Chief Scientific Officer | 卖出 | 154,000 | - | - | 2026-02-06 |